IL-33 antagonism does not improve chronic atopic dermatitis: What can we learn?

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 150; no. 6; pp. 1410 - 1411
Main Authors Schuler, Charles F., Gudjonsson, Johann E.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2022
Subjects
astegolimab
Atopic dermatitis
Dermatitis, Atopic - drug therapy
Eczema
Humans
IL-33
Interleukin-33
Protein Transport
ST2
ST2
astegolimab
Atopic dermatitis
IL-33
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Scholarly Journals-1
content type line 23
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:0091-6749
1097-6825
1097-6825
DOI:10.1016/j.jaci.2022.10.009